Yvo H A M Kusters
Overview
Explore the profile of Yvo H A M Kusters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wintjens M, van Rosmalen F, Hemmelder M, Hulsewe-Evers H, Kusters Y, Ubben J, et al.
J Nephrol
. 2023 Sep;
36(9):2669-2671.
PMID: 37668876
No abstract available.
2.
de Ritter R, Sep S, van Greevenbroek M, Kusters Y, Vos R, Bots M, et al.
Diabetologia
. 2023 Feb;
66(5):861-872.
PMID: 36805778
Aims/hypothesis: Obesity is a major risk factor for type 2 diabetes. However, body composition differs between women and men. In this study we investigate the association between diabetes status and...
3.
Van den Eynde M, Houben A, Scheijen J, Linkens A, Niessen P, Simons N, et al.
Diabetes Obes Metab
. 2023 Jan;
25(5):1280-1291.
PMID: 36655410
Aim: To investigate the effects of pyridoxamine (PM), a B6 vitamer and dicarbonyl scavenger, on glycation and a large panel of metabolic and vascular measurements in a randomized double-blind placebo-controlled...
4.
Tore E, Elshorbagy A, Bakers F, Brouwers M, Dagnelie P, Eussen S, et al.
Eur J Nutr
. 2022 Nov;
62(2):891-904.
PMID: 36322288
Purpose: Sulfur amino acids (SAAs) have been associated with obesity and obesity-related metabolic diseases. We investigated whether plasma SAAs (methionine, total cysteine (tCys), total homocysteine, cystathionine and total glutathione) are...
5.
Jin S, Kusters Y, Houben A, Plat J, Joris P, Mensink R, et al.
Obesity (Silver Spring)
. 2022 Jul;
30(7):1401-1410.
PMID: 35785477
Objective: Complement C3 and other components of the alternative pathway are higher in individuals with obesity. Moreover, C3 has been identified as a risk factor for cardiovascular disease. This study...
6.
Mashnafi S, Plat J, Mensink R, Joris P, Kusters Y, Houben A, et al.
Nutrients
. 2022 Apr;
14(8).
PMID: 35458107
Cross-sectional studies have shown that obesity is associated with lower intestinal cholesterol absorption and higher endogenous cholesterol synthesis. These metabolic characteristics have also been observed in patients with type 2...
7.
Van den Eynde M, Kusters Y, Houben A, Scheijen J, van Duynhoven J, Fazelzadeh P, et al.
Clin Nutr
. 2021 May;
40(5):2654-2662.
PMID: 33933731
Aims: Dicarbonyl compounds contribute to the formation of advanced glycation endproducts (AGEs) and the development of insulin resistance and vascular complications. Dicarbonyl stress may already be detrimental in obesity. We...
8.
Wouters K, Kusters Y, Bijnen M, Wetzels S, Zhang X, Linssen P, et al.
Clin Transl Med
. 2020 Nov;
10(6):e192.
PMID: 33135349
No abstract available.
9.
Joris P, Plat J, Kusters Y, Houben A, Stehouwer C, Schalkwijk C, et al.
Clin Nutr
. 2020 Jan;
39(10):2998-3004.
PMID: 31982191
Background: Effects of weight loss on postprandial vascular function have not been studied so far. We therefore examined (i) effects of diet-induced weight loss on postprandial changes in various vascular...
10.
Telgenkamp I, Kusters Y, Schalkwijk C, Houben A, Kooi M, Lindeboom L, et al.
J Clin Endocrinol Metab
. 2019 Feb;
104(7):2719-2727.
PMID: 30753672
Context: Hepatokines have emerged as potential mediators of obesity-associated comorbidities, such as type 2 diabetes, cardiovascular disease, fractures, and central hypogonadism. Objective: To assess whether weight loss-induced changes in hepatokines...